Depressive Episode Clinical Trials

7 recruiting

Depressive Episode Trials at a Glance

33 actively recruiting trials for depressive episode are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 18 trials, with the heaviest enrollment activity in Ottawa, Toronto, and Boston. Lead sponsors running depressive episode studies include Assistance Publique - Hôpitaux de Paris, Massachusetts General Hospital, and The Royal Ottawa Mental Health Centre.

Browse depressive episode trials by phase

Treatments under study

About Depressive Episode Clinical Trials

Looking for clinical trials for Depressive Episode? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Depressive Episode trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Depressive Episode clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 33 trials

Recruiting
Phase 1Phase 2

Personalized Ultrasonic Brain Stimulation for Depression (R61)

Depression - Major Depressive DisorderMajor Depressive EpisodeTreatment-Resistant Major Depressive Disorder
Brian Mickey30 enrolled1 locationNCT06902298
Recruiting
Not Applicable

Efficacy of Remote Monitoring in Patients Treated for Moderate to Severe Major Depressive Episodes

Mood Disorder (Depressive Episodes)
Resilience594 enrolled6 locationsNCT07087353
Recruiting
Phase 4

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

Depression - Major Depressive DisorderDepressive Episodes
Poznan University of Medical Sciences180 enrolled1 locationNCT07478796
Recruiting

LHC-CIDI-5 in Hong Kong

Suicidal IdeationMajor Depressive Disorder (MDD)Bipolar I Disorder+14 more
The University of Hong Kong2,500 enrolled1 locationNCT06804525
Recruiting

University of Iowa Interventional Psychiatry Service Patient Registry

Major Depressive DisorderMajor DepressionObsessive-Compulsive Disorder+4 more
Mark Niciu1,000 enrolled1 locationNCT04480918
Recruiting

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Long COVIDMajor Depressive DisorderMajor Depressive Episode
Centre for Addiction and Mental Health90 enrolled1 locationNCT06086366
Recruiting
Not Applicable

Chronotherapy for Depressive Episodes

Depressive Episode
St. Olavs Hospital76 enrolled1 locationNCT05691647
Recruiting
Not Applicable

Ketosis Impact on Signs & Symptoms of Schizophrenia and Bipolar disorderS

PsychosisDepressive EpisodeSchizophrenia and Related Disorders+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)24 enrolled1 locationNCT06426134
Recruiting
Not Applicable

Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression

DepressionDepressive Disorder, MajorDepressive Episode
The Royal Ottawa Mental Health Centre210 enrolled1 locationNCT06152705
Recruiting
Not Applicable

Improving Treatment for Depression in General Practice Using a Step-by-Step Care Plan.

DepressionDepressive DisorderDepression - Major Depressive Disorder+4 more
Aalborg University Hospital171 enrolled1 locationNCT07263321
Recruiting
Not Applicable

At-Home tDCS as Maintenance Therapy

Major Depressive EpisodeMDDSevere Depression
Technical University of Munich30 enrolled2 locationsNCT07269964
Recruiting
Not Applicable

Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)

DepressionAutism Spectrum DisorderMajor Depressive Episode (MDE)
Hospital Center Guillaume Régnier25 enrolled1 locationNCT07258914
Recruiting
Not Applicable

The Friendship Bench Plus Trial

Major Depressive DisorderSevere Depressive Episode Without Psychotic Symptoms
University of Bern296 enrolled1 locationNCT06384209
Recruiting
Not Applicable

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Primary CareMajor DepressionBipolar Disorder (BD)+1 more
University Hospital, Montpellier623 enrolled1 locationNCT07031817
Recruiting
Phase 2

BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study

Bipolar DisorderDepressive Episode
Massachusetts General Hospital30 enrolled1 locationNCT02481245
Recruiting
Phase 3

Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients

Major Depressive Episode
Assistance Publique - Hôpitaux de Paris60 enrolled4 locationsNCT06508710
Recruiting
Not Applicable

The Impact of Coach-guided Risk Communication on the Risk of Major Depression

Self EfficacyRisk ReductionMajor Depressive Episode
Dalhousie University1,000 enrolled1 locationNCT06619366
Recruiting
Not Applicable

Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)

DepressionMajor Depressive DisorderMajor Depressive Episode+1 more
NYU Langone Health40 enrolled1 locationNCT07111390
Recruiting
Not Applicable

A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression

Moderate DepressionSevere Depressive Episode Without Psychotic SymptomsRecurrent Depressive Disorder, Current Episode Moderate+1 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital117 enrolled1 locationNCT06005103
Recruiting
Phase 3

Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode

Suicidal IdeationMajor Depressive Episode
Centre Hospitalier Universitaire de Nīmes180 enrolled9 locationsNCT03646058